Daniel K. Hall-flavin MD, MS

Daniel Hall-Flavin, M.D., has an interest in addiction psychiatry and is currently involved in research that seeks to identify factors, including genetic factors, which render an individual susceptible to addiction and susceptible to relapse to use after recovery has been initiated.

His current research efforts involve the genetic basis of the altered metabolism of drugs used to treat alcoholism. Dr. Hall-Flavin is also interested in working with the Departmental Genomics study group in establishing a genomics database in addiction psychiatry.